CURRICULUM VITAE (CV) - Pasteur Institute of Iran

28. Ghasemi F, Davachi S, Nahrevanian H, Amini M, Hajihosseini R: Anti-leishmanial effects of L-
arginine as nitric oxide inducer and Indomethacin as prostaglandin inhibitor in Balb/c mice
infected with Leishmania major MRHO/IR/75/ER, Journal of The Iranian Chemical Society, 2009;
6(S1): P-10-201-1, S28-29.
29. Esmaeili B, Nahrevanian H, Kazemi M, Nazem H, Amini M: Biochemical evaluation of antimalarial
effects of Artemisia khorassanica extracts in vivo in murine malaria, Journal of The
Iranian Chemical Society, 2009; 6(S1): P-10-151-1, S119.
30. Farahmand M, Nahrevanian H, Atashi Shirazi H, Naderi S: Molecular genetics of A 2 proteins
analysis from Iranian Leishmania species, Journal of The Iranian Chemical Society, 2009; 6(S1):
P-10-586-1, S209.
31. Nahrevanian H: Leishmaniasis as a neglected tropical disease in the world, Eastern
Mediterranean Region and Iran, International Journal of Infectious Diseases, 2009; 13(S1): CS6-
01, S9.
32. Nahrevanian H, Eskandar Omidinia, Davachi S, Farahmand M, Amini M: Anti-leishmanial
effects of paromomycin in both cutaneous and visceral forms of Leishmania major infection in
Balb/c mice, International Journal of Infectious Diseases, 2009; 13(S1): PP-167, S94.
33. Nahrevanian H, Farahmand M, Amini M, M Arjmand, R Hajihosseini, F Ghasemi:
Immunotherapy of cutaneous leishmaniasis by inhibition of prostaglandin and induction of nitric
oxide in susceptible Balb/c infected with Leishmania major, International Journal of Infectious
Diseases, 2009; 13(S1): PP-168, S94.
34. Nahrevanian H, Kazemi M, Esmaeili B, Nazem H, Amini M, Naeimi S: Anti-malarial effects of
Iranian flora Artemisia khorassanica on experimental Plasmodium berghei infection and analysis
of its pharmacochemistry, International Journal of Infectious Diseases, 2009; 13(S1): PP-169,
S94.
35. Sharif M, Daryani A, Nasrolahei M, Nahravanian H, Rostami M: Evaluation of anti-leishmanial
efficacy by in vivo administration of herbal extract Artemisia auchery on Leishmania major in
Balb/c mice, International Journal of Antimicrobial Agents, 2009; 34(S2): P250, S105.
36. Farahmand M, Atashi Shirazi H, Nahrevanian H: Molecular survey of A2 proteins in leishmania
species from endemic areas in Iran, Tropical Medicine and International Health, 2009; 14(S1):
182-183.
37. Rustaiyan A, Nahrevanian H, Kazemi M: Tehranolide, A sesquiterpene lactone with an
endoperoxide group that probably has the same effect as the antimalarial agent Artemisinin,
Planta Medica, 2009; 75(9): 944.
38. Sadeghi Tafreshi AR, Zamani Z, Nahrevanian H, Arjmand M, Sadeghi S, Lame-Rad B,
Pourfallah F: Study of Gluthatione-S-transferase enzyme activity in rodent and human malaria
(Plasmodium berghei and Plasmodium falciparum). Clinical Chemistry and Laboratory Medicine,
2009; 47(402): p S248-S256.
39. Nahrevanian H, Najafzadeh M, Farahmand M, Zamani Z, Hajihosseini R: Immunobiochemical
evaluation of antileishmanial effects of trinitroglycerin as nitric oxide donor in BALB/C mice
infected with Leishmania major MRHO/IR/75/ER. Nitric Oxide, Biology & Chemistry, 2008;
19(Suppl1): p62.
40. Nahrevanian H, Esmaeilnejad S, Khatami Sh, Hajihosseini R, Aghighi Z, Javadian S:
Antimalarial effects of nitric oxide synthetic metabolite (S-nitrate) as a novel therapy for in vivo
treatment of Plasmodium berghei NY. Nitric Oxide, Biology & Chemistry, 2008; 19(Suppl1): p68.
41. Mohajeri M, Shamsian SAA, Mahmoudi M, Nahrevanian H, Yazdanpanah SMJ, Shahi M: The
role of IL-10 and IFN-γ in resistance and sensitive patients under treatment with Glucantime in
Mash had. Iranian J Prasitology, 2008; 3(1) Suppl1: p27.
42. Nahrevanian H, Ghasemi F, Amini M, Farahmand M, Arjmand M, Hajihosaini R:
Immunobiochemical evaluation of prostaglandin and nitric oxide in the physiopathology of Balb/c
mice infected with Leishmania major. Iranian J Prasitology, 2008; 3(1) Suppl1: p59.
Page 9 of 27 CV (Dr H Nahrevanian) 09/01/2013